Page last updated: 2024-09-04

tezosentan and Sepsis

tezosentan has been researched along with Sepsis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goraca, A; Kleniewska, P; Kolodziejczyk, M; Kowalczyk, A; Skibska, B1
Arner, A; Boels, PJ; Oldner, A; Persson, B; Rossi, P; Weitzberg, E1

Reviews

1 review(s) available for tezosentan and Sepsis

ArticleYear
The role of endothelin-1 and endothelin receptor antagonists in inflammatory response and sepsis.
    Archivum immunologiae et therapiae experimentalis, 2015, Volume: 63, Issue:1

    Topics: Animals; Bosentan; Cytokines; Endothelin Receptor Antagonists; Endothelin-1; Humans; Inflammation; Lipopolysaccharides; NF-kappa B; Oligopeptides; Peptides, Cyclic; Piperidines; Pyridines; Reactive Oxygen Species; Sepsis; Signal Transduction; Sulfonamides; Superoxides; Tetrazoles

2015

Other Studies

1 other study(ies) available for tezosentan and Sepsis

ArticleYear
Endotoxemic pulmonary hypertension is largely mediated by endothelin-induced venous constriction.
    Intensive care medicine, 2008, Volume: 34, Issue:5

    Topics: Animals; Ciprofloxacin; Endothelin-1; Female; Hypertension, Pulmonary; Lipopolysaccharides; Lung; Male; Pyridines; Respiratory Distress Syndrome; Sepsis; Swine; Tetrazoles; Vascular Resistance; Vasoconstriction; Vasodilator Agents

2008